Should You Buy Catalyst Biosciences Inc (CBIO) Stock After it Has Risen 4.17% in a Week?

Wednesday, March 01, 2023 01:04 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Catalyst Biosciences Inc (CBIO) Stock After it Has Risen 4.17% in a Week?

Overall market sentiment has been high on Catalyst Biosciences Inc (CBIO) stock lately. CBIO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Catalyst Biosciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on CBIO!

See Full CBIO Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CBIO Stock Today?

Catalyst Biosciences Inc (CBIO) stock is trading at $0.25 as of 1:00 PM on Wednesday, Mar 1, a decline of -$0.05, or -17.37% from the previous closing price of $0.30. The stock has traded between $0.24 and $0.27 so far today. Volume today is high. So far 2,479,995 shares have traded compared to average volume of 1,820,007 shares. To screen for more stocks like Catalyst Biosciences Inc click here.

More About Catalyst Biosciences Inc

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants. Click Here to get the full Stock Report for Catalyst Biosciences Inc stock.